News

Net profit of Vaxfab Enterprises rose 68.72% to Rs 3.02 crore in the quarter ended March 2026 as against Rs 1.79 crore during the previous quarter ended March 2025. Sales rose 176.80% to Rs 8.83 crore in the quarter ended March 2026 as against Rs 3.19 crore during the previous quarter ended March 2025.For the full year,net profit rose 527.59% to Rs 3.64 crore in the year ended March 2026 as against Rs 0.58 crore during the previous year ended March 2025. Sales rose 60.41% to Rs 94.11 crore in the year ended March 2026 as against Rs 58.67 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales8.833.19 177 94.1158.67 60 OPM %-28.8858.62 --0.310.03 - PBDT6.981.92 264 5.200.73 612 PBT6.971.91 265 5.170.70 639 NP3.021.79 69 3.640.58 528 Powered by Capital Market - Live News

Vaxfab Enterprises will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Vaxfab Enterprises has allotted 19,50,348 equity shares on conversion of warrants on 11 May 2026. Post allotment, the paid up equity share capital has increased to Rs. 25,46,89,250 /- comprising 2,54,68,925 equity shares of face value of Rs. 10/- each.

Vaxfab Enterprises has allotted 13,18,550 equity shares on conversion of warrants. Post allotment, the paid up equity share capital has increased to Rs. 23,51,85,770 /- comprising 2,35,18,577 equity shares of face value of Rs. 10/ each.

Vaxfab Enterprises will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live News